A X Zhu Selected Research

Hepatitis

9/2010

The role of signaling pathways in the development and treatment of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A X Zhu Research Topics

Disease

5	Neoplasms (Cancer) 01/2019 - 07/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 07/2007
2	Hypertension (High Blood Pressure) 12/2017 - 04/2013
2	Adenocarcinoma 07/2014 - 06/2011
2	Neutropenia 04/2013 - 03/2009
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Hemorrhage 12/2017
1	Proteinuria 12/2017
1	Ischemia 09/2014
1	Reperfusion Injury 09/2014
1	Hypoxia (Hypoxemia) 09/2014
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 07/2014
1	Gallbladder Neoplasms (Gallbladder Cancer) 07/2014
1	Rectal Neoplasms (Rectal Cancer) 01/2014
1	Pathologic Complete Response 01/2014
1	Stroke (Strokes) 04/2013
1	Lymphopenia (Lymphocytopenia) 04/2013
1	Pulmonary Embolism 04/2013
1	Thrombocytopenia (Thrombopenia) 04/2013
1	Carcinoma (Carcinomatosis) 06/2011
1	Hepatitis 09/2010
1	Infections 09/2010
1	Fibrosis (Cirrhosis) 09/2010
1	Nausea 03/2009
1	Anorexia 03/2009
1	Thrombosis (Thrombus) 03/2009
1	Fatigue 03/2009
1	Embolism (Embolus) 03/2009
1	Diarrhea 03/2009

Drug/Important Bio-Agent (IBA)

3	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 07/2007
2	Monoclonal AntibodiesIBA 12/2017 - 06/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2014 - 07/2007
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014 - 07/2007
2	Bevacizumab (Avastin)FDA Link 01/2014 - 07/2007
2	ErbB Receptors (EGF Receptor)IBA 06/2011 - 07/2007
1	CateninsIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	HydrocarbonsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	RamucirumabIBA 12/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2017
1	Angiogenesis InhibitorsIBA 12/2017
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	salicylhydroxamic acid (SHAM)IBA 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014
1	PlatinumIBA 07/2014
1	Gemcitabine FDA Link 07/2014
1	Panitumumab (Vectibix)FDA Link 07/2014
1	Uric Acid (Urate)IBA 04/2013
1	Cetuximab (Erbitux)FDA Link 06/2011
1	Tyrosine Kinase InhibitorsIBA 06/2011
1	AflatoxinsIBA 09/2010
1	Cisplatin (Platino)FDA LinkGeneric 03/2009
1	Docetaxel (Taxotere)FDA Link 03/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2009
1	Leucovorin (Folinic Acid)FDA Link 07/2007
1	MAC321IBA 07/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2007

Therapy/Procedure

6	Therapeutics 01/2019 - 07/2007
1	Ischemic Postconditioning 09/2014
1	Radiotherapy 01/2014